12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Ampion: Phase III started

Ampio began a 2-part, double-blind, placebo-controlled Phase III trial of Ampion. The first run-in portion will compare 4 and 10 mL injections of Ampion in 320 patients and will determine the optimal dose...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >